Rizatriptan benzoate and Botox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rizatriptan benzoate (rizatriptan benzoate) and Botox (botulinum toxin type a). Common drug interactions include pyrexia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Rizatriptan benzoate and Botox. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Rizatriptan benzoate?

Rizatriptan benzoate has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,886 Rizatriptan benzoate users. Check the latest studies of Rizatriptan benzoate.

What is Botox?

Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,513 Botox users. Check the latest studies of Botox.

On Jul, 06, 2026

53 people who take Rizatriptan benzoate and Botox together, and have interactions are studied.

Rizatriptan benzoate and Botox drug interactions.

What are the common drug interactions of Rizatriptan Benzoate and Botox, by gender? *:

female:

Pyrexia (fever)
Nasopharyngitis (inflammation of the nasopharynx)
Pneumonia
Rash
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Urinary tract infection
Muscle spasms (muscle contraction)
Fall
Sinusitis (inflammation of sinus)
Abdominal pain

male:

Drug ineffective
Hyperhidrosis (abnormally increased sweating)
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)
Nightmare (unpleasant dream)
Sedation

What are the common drug interactions of Rizatriptan Benzoate and Botox, by age (0-1 to 60+)? *:

0-1:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Tricuspid valve incompetence (inefficient heart valve)

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Asthenia (weakness)
Diarrhoea
Ear discomfort
Fatigue (feeling of tiredness)
Flushing (the warm, red condition of human skin)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)

30-39:

Anxiety
Blood glucose increased
Body mass index increased
Cd4 lymphocytes decreased
Depression
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
Dry skin
Dysphagia (a condition in which swallowing is difficult or painful)
Fatigue (feeling of tiredness)
Headache (pain in head)

40-49:

Asthma
Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Heart rate irregular
Infection
Influenza
Pneumonia
Pyrexia (fever)
Sinusitis (inflammation of sinus)
Upper airway obstruction

50-59:

Nausea (feeling of having an urge to vomit)
Drug ineffective
Abdominal pain upper
Back pain
Breast abscess
Cough
Electrocardiogram qt prolonged
Fall
Fatigue (feeling of tiredness)
Impaired healing

60+:

Anaphylactic reaction (serious allergic reaction)
Drug intolerance (drug sensitivity)
Nephrolithiasis (calculi in the kidneys)
Pneumonia
Poor venous access
Post procedural infection
Sleep disorder
Urinary tract infection
Weight decreased
White blood cell count decreased

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 19 people, 35.85%
Nausea (feeling of having an urge to vomit): 6 people, 11.32%
Pain: 5 people, 9.43%
Hypersensitivity: 5 people, 9.43%
Muscle Spasms (muscle contraction): 4 people, 7.55%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 7.55%
Dizziness: 4 people, 7.55%
Asthma: 4 people, 7.55%
Affective Disorder (mental disorder): 4 people, 7.55%
Pneumonia: 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Rizatriptan benzoate and Botox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously